Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
NCT ID:
NCT00631150
Eligibility Criteria:
Inclusion Criteria:
* partial onset seizures with or without secondary generalisation with epilepsy.
Exclusion Criteria:
* hypersensitivity to levetiracetam or other pyrrolidone derivatives or to any of the excipients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00631150
Study Brief:
Protocol Section:
NCT00631150